Drug Effectiveness

((A-075)) (A-075) Comparative effectiveness and safety of fixed-dose combination inhaled triple therapies in patients with chronic obstructive pulmonary disease: a population-based cohort study

((A-076)) (A-076) Continuation versus discontinuation of SGLT2is and cardiorenal outcomes among patients with type 2 diabetes and chronic kidney disease: a nationwide cohort study with a target trial emulation framework

((A-077)) (A-077) Association between early methadone dose titration and opioid toxicity and discontinuation: A population-based cohort study

((A-078)) (A-078) Comparative Effectiveness of GLP-1 Receptor Agonists and SGLT2 Inhibitors in Heart Failure with Preserved Ejection Fraction: A Network Meta-Analysis

((A-080)) (A-080) Real-world Effectiveness of GLP-1RA for New-Onset Pan Cancer Outcomes: A Debiased Target Trial Emulation Study on Penn EHR study

((A-081)) (A-081) Effect of Orlistat on Bodyweight Among Adults With Overweight or Obesity Without Diabetes: Emulation of a Target Trial Using UK Electronic Medical Records

((A-082)) (A-082) Impact of New Antidiabetic Medications on Weight Loss in People with HIV

((A-083)) (A-083) Real-world Effectiveness of Interleukin-6 Receptor Inhibitors Compared to Methotrexate in Steroid-refractory Frail Patients with Polymyalgia Rheumatica

((A-084)) (A-084) Effectiveness and Safety of Vortioxetine versus Other Antidepressants in Patients with Major Depression Disorder

((A-085)) (A-085) Association Between Metformin Use and Mortality Among Individuals With Non-Small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors: A Retrospective Cohort Study

((A-086)) (A-086) Weight Changes from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1) Use and Discontinuation: A Retrospective Cohort Study of Electronic Health Records

((A-087)) (A-087) Effect of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) in Alcohol Use Disorder: A Retrospective Cohort Study Using Electronic Health Records

((A-088)) (A-088) Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Autoimmune Rheumatic Diseases: A Population-based Cohort Study

((A-089)) (A-089) Risk of obstructive sleep apnea associated with the use of SGLT2 inhibitors in patients with type 2 diabetes: A nationwide cohort study

((A-090)) (A-090) Effectiveness and waning of the fourth dose mRNA COVID-19 vaccines for the prevention of severe COVID-19 related outcomes

((A-091)) (A-091) Long-Term Effects of Symptomatic Treatments in Alzheimer's Disease and Related Dementias

((A-092)) (A-092) Vitamin K Antagonists And Direct Oral Anticoagulants Are Equal For Recurrent Venous Thromboembolism Prevention In Patients With Anorexia Nervosa: A Nationwide Cohort Study

((A-093)) (A-093) Comparative Safety and Effectiveness of Apixaban and Rivaroxaban for Treatment of Cancer-Associated Venous Thromboembolism: A Retrospective Cohort Study

((A-094)) (A-094) Efficacy of SodiumGlucose Co-transporter2 Inhibitors in Patients with Heart Failure: An Open Labelled Randomized Study

((A-095)) (A-095) Efficacy and Safety of APOC3-Targeting Therapies, Olezarsen and Plozasiran in Severe Hypertriglyceridemia: A Meta-Analysis of Randomized Controlled Trials

((A-096)) (A-096) The association between angiotensin-converting enzyme inhibitors and the risk of diabetic retinopathy in patients with type 2 diabetes: a population-based real world study

((A-097)) (A-097) Comparative effectiveness of etelcalcetide versus cinacalcet for the treatment of secondary hyperparathyroidism in patients in haemodialysis: a population-based study in Lazio, Italy

((A-098)) (A-098) Glucagon-Like Peptide-1 Receptor Agonists for the Prevention of Genitourinary Cancers: A Systematic Review of Observational Studies

((A-099)) (A-099) Effectiveness of an intravenous amino acid treatment on outcomes in sepsis: a nationwide population-based cohort study

((A-100)) (A-100) Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in older adults with type 2 diabetes mellitus: a target trial emulation study

((A-101)) (A-101) Salient features and related variables with the possibility of initial antidepressant modification: A prospective study in a tertiary-care teaching hospital in India

((A-102)) (A-102) Addressing methodological challenges in estimating treatment effects using external controls in rare disease clinical trials when controls cross over to open label treatment

((A-103)) (A-103) Comparative efficacy and safety of CFTR modulators for people with cystic fibrosis with phe508del mutation: a systematic review and bayesian network meta-analysis

((A-104)) (A-104) Heterogeneity of treatment effects of glucagon-like peptide-1 receptor agonists (GLP-1 RA's) for weight loss among adults: A systematic review and meta-analysis of randomized trials

((A-105)) (A-105) Transporting the effects of lung cancer screening from the National Lung Screening Trial (NLST) to a nationally representative US screening-eligible population

((A-106)) (A-106) Heterogeneity of Treatment Effects of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1) on Weight Loss: A Retrospective Cohort Study

((A-107)) (A-107) Glucagon-like Peptide-1 Receptor Agonists and Reduced Risk of New-Onset Atopic Dermatitis in Patients with Type 2 Diabetes: A Nationwide, Active-Comparator Study

((A-108)) (A-108) Impact of Treatment Sequencing, and Age on Survival in Metastatic Castration-Resistant Prostate Cancer: A National Health Insurance Database Study

((A-109)) (A-109) Effectiveness and Tolerability of Cannabidiol in Children with Drug-Resistant Epilepsy: A Real-world Multicentric Ambispective Study in India

((A-110)) (A-110) Risk of Hepatocellular Carcinoma after Kidney Transplantation in Patients with End-Stage Renal Disease: A Population-based Cohort Study Using Multi-Institutional Electronic Health Records

((A-111)) (A-111) Efficacy and Safety of Pharmacological Interventions for Pulmonary Arterial Hypertension (PAH): A Systematic Review and Network Meta-Analysis (NMA) of Randomized Controlled Trials (RCTs)

((A-112)) (A-112) Direct Oral Anticoagulants and Incidence of Dementia in Patients with Nonvalvular Atrial Fibrillation

((A-113)) (A-113) Dosage adjustment pattern of renin-angiotensin system inhibitors in heart failure patients with severe renal dysfunction: A Nationwide Cohort

((A-114)) (A-114) Effects of Different Sedation Regimens on Mortality in Post-Cardiac Surgery Patients: A Target Trial Emulation Study

((A-115)) (A-115) Impact of 5-Alpha Reductase Inhibitors (5-ARIs) in Prostate Cancer Risk Reduction in Patients with Negative Prostate Biopsy: A Systematic Review and Meta-Analysis.

((A-116)) (A-116) Efficacy and Safety of PI3K/Akt/mTOR Inhibitors Combined with Taxane Therapy for Treatment of Breast Cancer: A Systematic Review and Meta-Analysis

((A-117)) (A-117) Comparison of the Hypocalcemia Risk between Denosumab and Bisphosphonates in Patients with Osteoporosis and CKD – A Target Trial Emulation Study Using Multi-Institutional Electronic Health Records

((A-118)) (A-118) Comparative Efficacy and Safety of Acalabrutinib Monotherapy in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis

((A-119)) (A-119) Real-World Effectiveness of Low-Dose Nivolumab Plus Triple Metronomic Chemotherapy in Recurrent/Metastatic HNSCC: A Pragmatic Approach for Resource-Limited Settings

((A-120)) (A-120) Association of SGLT2 Inhibitors and GLP-1 Receptor Agonists with the Risk of Parkinson’s Disease in Patients with Type 2 Diabetes: A Propensity Score-Matched Cohort Study

((A-121)) (A-121) Real-World Effectiveness of Ravulizumab in Adults With aHUS who Switched to Ravulizumab Within 3 Months of Eculizumab Treatment (aHUS IMPACT)

((A-122)) (A-122) The Effectiveness of HPV Vaccination in Women Younger Than 18 Years Old to Prevent HPV-Related Pre-Cancerous Lesions and Cancers: a UK Population-Based Cohort Study

((A-123)) (A-123) A comparative efficacy of anti-fibrotic drugs on NASH: A systematic review and Network meta-analysis

((A-124)) (A-124) Evaluating effectiveness of ibalizumab among highly treatment experienced people with HIV: an externally controlled trial

((A-125)) (A-125) Impact of GLP-1 Receptor Agonists versus DPP-4 Inhibitors and SGLT-2 Inhibitors on Asthma Exacerbations Among Individuals with Asthma and Type 2 Diabetes: A Target Trial Emulation Study

((A-126)) (A-126) GLP-1 Receptor Agonists and Risk of Osteoarthritis Among Patients with Type 2 Diabetes: A Population-Based Cohort Study

((A-127)) (A-127) Comparative 1‐Year Survival Among Hypertensive Alzheimer’s Disease Patients Receiving Donepezil Versus Memantine: A Target Trial Emulation Study

((A-128)) (A-128) Prevalence And Factors of Erythropoietin Hyporesponsiveness in Chronic Kidney Disease Patients Undergoing Hemodialysis At A Public Sector Tertiary Care Teaching Hospital in Kerala: A Cross-Sectional Study

((A-129)) (A-129) Sex differences in the comparative effectiveness of second-line antidiabetic medications at preventing cardiovascular outcomes

((A-130)) (A-130) Prevalence of Drug-Gene Interactions Following Acute Myocardial Infarction: An Observational Study Using Data From the UK Biobank

((A-131)) (A-131) Medications with anti-inflammatory mechanisms and risk of non-small cell lung cancer (NSCLC): A population-based case-control study in the US using SEER-Medicare data

((A-132)) (A-132) Comparative Effectiveness of Empagliflozin and Dapagliflozin in Patients with Heart Failure Without Diabetes: A Real-World Analysis

((A-133)) (A-133) Decreased Risk of Clinical Gallstone Disease in New-Users of Statins

((A-134)) (A-134) Increased Risk of Clinical Gallstone Disease in New-Users of Calcium Channel Blockers

((A-135)) (A-135) Impact of Immune-Modulating Treatment on Progression from Mild Cognitive Impairment to Alzheimer’s Disease: A US Administrative Healthcare Claims Cohort Study

((A-136)) (A-136) Comparison Of Tamsulosin And Dutasteride Combination Versus Silodosin And Dutasteride Combination In Patients With Benign Prostatic Hyperplasia